Neurocan

Neurocan is a large chondroitin sulfate proteoglycan that is predominantly expressed in the central nervous system (CNS). It is a member of the lectican family, which also includes aggrecan, versican, and brevican. Neurocan plays a crucial role in the modulation of cell adhesion, neuronal migration, and the plasticity of neuronal networks. Its expression is highly dynamic and varies during development and in response to neuronal activity, injury, and disease.

Structure[edit | edit source]

Neurocan is composed of a core protein with one or more covalently attached glycosaminoglycan (GAG) chains, predominantly chondroitin sulfate. The core protein contains several domains, including an N-terminal C-type lectin domain, EGF-like domains, and a C-type lectin domain, which are involved in its interactions with other molecules in the extracellular matrix (ECM) and on cell surfaces.

Function[edit | edit source]

Neurocan contributes to the structure of the extracellular matrix in the brain and influences the behavior of neurons and other cells within the CNS. It is involved in the regulation of cell adhesion by interacting with other ECM components and cell surface receptors, thereby modulating cell migration and neurite outgrowth. Neurocan can act as both a promoter and inhibitor of neurite outgrowth, depending on the cellular context and the presence of other ECM molecules.

During CNS development, neurocan is expressed at high levels and is thought to play a role in the formation of synaptic connections by inhibiting the interaction between neurons. In the adult brain, its expression is lower but can be upregulated in response to injury, such as after a spinal cord injury or in neurodegenerative diseases like Alzheimer's disease. This upregulation is associated with the formation of a glial scar and can inhibit axonal regeneration and functional recovery.

Clinical Significance[edit | edit source]

The dynamic regulation of neurocan expression in the CNS suggests that it plays a significant role in both development and response to injury. Understanding the mechanisms that control its expression and function could lead to new therapeutic strategies for enhancing neural repair and regeneration. For example, targeting neurocan or its interactions with other molecules could potentially modulate the inhibitory environment of the glial scar, promoting axonal growth and functional recovery after CNS injuries.

Research Directions[edit | edit source]

Current research on neurocan is focused on elucidating its interactions with other ECM components and cell surface receptors, as well as understanding how these interactions influence neuronal behavior and plasticity. Studies are also exploring the potential of targeting neurocan in therapeutic approaches for CNS injuries and neurodegenerative diseases.